I. Ceglia

发表

A novel interaction between megakaryocytes and activated fibrocytes increases TGF-β bioavailability in the Gata1(low) mouse model of myelofibrosis.

A. Ruggeri, A. Migliaccio, R. Rana, 2015, American journal of blood research.

Proteasome inhibition and aggregation in Parkinson's disease: a comparative study in untransfected and transfected cells

G. Forloni, R. Chiesa, L. Fioriti, 2003, Journal of neurochemistry.

Predominance of CK2α over CK2α′ in the mammalian brain

M. Flajolet, H. Rebholz, I. Ceglia, 2011, Molecular and Cellular Biochemistry.

Phosphorylation of WAVE1 regulates actin polymerization and dendritic spine morphology

P. Greengard, A. Nairn, John D. Scott, 2006, Nature.

APP intracellular domain/WAVE1 pathway reduces amyloid β production

P. Greengard, A. Nairn, C. Reitz, 2015, Nature Medicine.

Effects of chronic treatment with escitalopram or citalopram on extracellular 5‐HT in the prefrontal cortex of rats: role of 5‐HT1A receptors

S. Caccia, C. Fracasso, R. Invernizzi, 2004, British journal of pharmacology.

Preclinical rationale for TGF-β inhibition as a therapeutic target for the treatment of myelofibrosis.

E. Petricoin, A. Dueck, R. Hoffman, 2016, Experimental hematology.

SMARCA3, a Chromatin-Remodeling Factor, Is Required for p11-Dependent Antidepressant Action

P. Greengard, B. Chait, D. Patel, 2013, Cell.

p‐Methylthioamphetamine and 1‐(m‐chlorophenyl)piperazine, two non‐neurotoxic 5‐HT releasers in vivo, differ from neurotoxic amphetamine derivatives in their mode of action at 5‐HT nerve endings in vitro

M. Gobbi, L. Pirona, M. Reyes-Parada, 2002, Journal of neurochemistry.

Signaling pathways controlling the phosphorylation state of WAVE1, a regulator of actin polymerization

P. Greengard, A. Nairn, I. Ceglia, 2010, Journal of neurochemistry.

WAVE1 in neurons expressing the D1 dopamine receptor regulates cellular and behavioral actions of cocaine

Steven M. Graves, P. Greengard, A. Nairn, 2017, Proceedings of the National Academy of Sciences.

The 5‐HT2A receptor antagonist M100,907 prevents extracellular glutamate rising in response to NMDA receptor blockade in the mPFC

M. Carli, E. Calcagno, R. Invernizzi, 2004, Journal of neurochemistry.

Stimulation of 5‐hydroxytryptamine (5‐HT2C) receptors in the ventrotegmental area inhibits stress‐induced but not basal dopamine release in the rat prefrontal cortex

L. Pozzi, R. Samanin, R. Invernizzi, 2002, Journal of neurochemistry.

Preclinical rationale for TGF-β inhibition as a therapeutic target for the treatment of myelofibrosis.

E. Petricoin, A. Dueck, R. Hoffman, 2016, Experimental hematology.